SGMO vs WAB · rev $57.8M vs P/E 38, rev $3.18B
Sangamo Therapeutics Inc (SGMO) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Sangamo Therapeutics Inc (SGMO) is a biotechnology company listed on NASDAQ.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported SGMO revenue for 2024-12-31 was $57.8M. Net income was -$97.9M. Revenue was down 67.2% from 2023-12-31 to 2024-12-31. SGMO currently screens at market cap $74.6M.
Latest reported WAB revenue for 2026-06-30 was $3.18B. Net income was $395.0M. Revenue was up 7.8% from 2026-03-31 to 2026-06-30. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
SGMO currently screens at market cap $74.6M. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the SGMO and WAB stock pages for the full models.
Not investment advice.